Clinical Trials Browser

Phase 1 × nintedanib × 1 year × Clear all

NCT02856425 2026-01-20

PEMBIB

Phase 1 Completed

Other solid neoplasm

Patients With Any Advanced Solid Tumors

NCT03513484 2025-10-21

Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute